About
Coastar Therapeutics develops biological payload delivery technologies for immunotherapies and gene therapies using a human erythrocyte-derived cell membrane encapsulation system designed to reduce immune recognition and clearance.
Explore Coastar Therapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.